Skip to main content
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published loading...Updated

One Historic Week for Flu: Generic Xofluza Approved June 17, mRNA Flu Vaccine VRBPAC Vote June 18 — Here's What Both Mean for 2026–27

Summary by Medical Daily
FDA approved generic baloxavir June 17; VRBPAC voted on mRNA flu vaccine June 18. The 2025–26 flu season killed 24,000 Americans. Here's what both mean for 2026–27.

3 Articles

The Food and Drug Administration is valuing this new injection of Moderna, which is called mFlusive, directed Americans who are adults. For its part, the U.S. biotechnology company and which is a pioneer in messenger RNA drugs (MRNA), seeks total approval for this new vaccine for people between 50 and 64 years of age, “along with authorization for its use in those who are 65 years of age or older while performing additional tests,” describes The…

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe
Father's Day SaleGet 40% off Vantage subscriptions for yourself or a friend.Get Started

Bias Distribution

  • 50% of the sources lean Left, 50% of the sources are Center
50% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Vanguardia broke the news on Friday, June 19, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal